During the past decade, UMA Research Department conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UMA Research Department" are "Chronic Hepatitis" (2 trials) and "Hepatitis B" (2 trials). Many other conditions were trialed in "UMA Research Department" in a lesser frequency.

Most popular intervention types in "UMA Research Department" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adefovir" (2 trials) and "Clevudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "UMA Research Department" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UMA Research Department". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UMA Research Department, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UMA Research Department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".